These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 7698213)

  • 21. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
    Shukla VK; Turndorf H; Bansinath M
    Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.
    Riviere PJ; Pascaud X; Chevalier E; Junien JL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):846-50. PubMed ID: 7932195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys.
    Endoh T; Tajima A; Izumimoto N; Suzuki T; Saitoh A; Suzuki T; Narita M; Kamei J; Tseng LF; Mizoguchi H; Nagase H
    Jpn J Pharmacol; 2001 Mar; 85(3):282-90. PubMed ID: 11325021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
    Wettstein JG; Grouhel A
    Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the kappa-opioid agonist U50,488 on parturition in rats.
    Douglas AJ; Clarke G; MacMillan SJ; Bull PM; Neumann I; Way SA; Wright DM; McGrory BG; Russell JA
    Br J Pharmacol; 1993 May; 109(1):251-8. PubMed ID: 8388299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrasting actions of intrathecal U50,488H, morphine, or [D-Pen2, D-Pen5] enkephalin or intravenous U50,488H on the visceromotor response to colorectal distension in the rat.
    Harada Y; Nishioka K; Kitahata LM; Nakatani K; Collins JG
    Anesthesiology; 1995 Aug; 83(2):336-43. PubMed ID: 7631956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
    Przewłocka B; Lasoń W; Machelska H; van Luijtelaar G; Coenen A; Przewłocki R
    Neurosci Lett; 1995 Feb; 186(2-3):131-4. PubMed ID: 7777181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
    Xu JY; Tseng LF
    Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat.
    Bonaz B; Rivière PJ; Sinniger V; Pascaud X; Junien JL; Fournet J; Feuerstein C
    Neurogastroenterol Motil; 2000 Apr; 12(2):135-47. PubMed ID: 10771495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
    Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
    Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.